UK cost agency wants more data on Bayer’s anti-clot drug
by on Jan.09, 2012, under Health and Fitness
LONDON (Reuters) – Britain's health costs watchdog is asking Bayer for more information on its anti-clotting drug Xarelto before deciding whether to recommend it for use on the state health service. The National Institute for Health and Clinic…
View full post on Yahoo! Health News
